Bridgeway Capital Management, LLC Palatin Technologies Inc Transaction History

Bridgeway Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.34 - $0.86 $61,540 - $155,660	-181,000 Reduced 20.95%	683,100 $349,000
Q3 2021 Nov 15, 2021	SELL	$0.44 - $0.63 $83,600 - $119,700	-190,000 Reduced 18.02%	864,100 $383,000
Q2 2021 Aug 16, 2021	SELL	$0.48 - $0.72 $93,600 - $140,400	-195,000 Reduced 15.61%	1,054,100 $643,000
Q4 2020 Feb 16, 2021	SELL	$0.38 - $0.78 $47,500 - $97,500	-125,000 Reduced 9.1%	1,249,100 $844,000
Q2 2020 Aug 14, 2020	BUY	$0.41 - $0.73 $319,021 - $568,013	778,100 Added 130.55%	1,374,100 $704,000
Q1 2020 May 15, 2020	SELL	$0.36 - $0.79 $72,000 - $158,000	-200,000 Reduced 25.13%	596,000 $252,000
Q2 2018 Aug 14, 2018	BUY	$0.91 - $1.45 $227,500 - $362,500	250,000 Added 45.79%	796,000 $772,000
Q4 2017 Feb 14, 2018	BUY	$0.68 - $1.0 $371,280 - $546,000	546,000	546,000 $469,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.27M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.